Catalyst dives as FDA approves rival's rare disease drug

Catalyst dives as FDA approves rival's rare disease drug

Source: 
Biopharma Dive
snippet: 

The Food and Drug Administration has approved a rare disease drug from family-owned Jacobus Pharmaceutical, a decision that could present a competitive threat to Catalyst Pharmaceuticals.